Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 266-369-7 | CAS number: 66469-15-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
Amest Test: Potassium isostearate did not cause gene mutations by base pair changes or frameshifts in the genome of the tester strains used. Therefore the test item is considered to be non-mutagenic in this bacterial reverse mutation assay.
MLA: Potassium isostearate, tested up to the cytotoxic concentration of 100 µg/mL medium, in two independent experiments was negative with respect to the mutant frequency in the L5178Y TK +/- mammalian cell mutagenicity test. In addition, no test item-related change was noted in the ratio of small to large mutant colonies. Therefore the test item also did not exhibit any clastogenic potential at the concentration-range investigated.
MNT: Under the present test conditions, potassium isostearate tested up to the cytotoxic concentration of 100 µg/mL medium in the absence and in the presence of metabolic activation employing two exposure times (without S9) and one exposure time (with S9) using human peripheral lymphocytes revealed no indications of chromosomal damage in the in vitro micronucleus test.
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2017
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- no
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- bacterial reverse mutation assay
- Specific details on test material used for the study:
- Product description: Potassium isooctadecanoate/potassium isostearate
Name: Isooctadecanoic acid, potassium salt
CAS No.: 66469-15-6
Physical state: off white to yellowish solid at 20 °C
Batch No.: PFS-755-169
Re-certification date of batch: 12 December 2017
Purity: 100 % (UVCB)
pH, 10% in DI water 8.0 - 9.0
Stability: stable under test conditions
Storage condition of test material: Room temperature, protected from light - Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and E. coli WP2
- Metabolic activation:
- with and without
- Metabolic activation system:
- Mammalian Microsomal Fraction S9 Mix
- Test concentrations with justification for top dose:
- The toxicity of the test item was determined with tester strains TA 98 and TA 100 in a pre-experiment. Eight concentrations were tested for toxicity and induction of mutations with three plates each. The experimental conditions in this pre-experiment were the same as described below for the main experiment I (plate incorporation test). Toxicity may be detected by a clearing or rather diminution of the background lawn or a reduction in the number of revertants down to a mutation factor of approximately ≤ 0.5 in relation to the solvent control.
The test item was tested in the pre-experiment at the following concentrations: 3.16, 10.0, 31.6, 100, 316, 1000, 2500 and 5000 µg/plate
The test item concentrations to be applied in the main experiments were chosen according to the results of the pre-experiment. 5000 µg/plate was selected as the maximum concentration. The concentration range covered two logarithmic decades. Two independent experiments were performed at the following concentrations:
Experiment I:
31.6, 100, 316, 1000, 2500 and 5000 µg/plate
Experiment II:
5.0, 15.8, 50.0, 158, 500, 1580 and 5000 µg/plate
As the results of the pre-experiment were in accordance with the criteria described above, these were reported as a part of the main experiment I. - Vehicle / solvent:
- Water; The test item was completely dissolved in aqua ad iniectabilia at the evaluated concentrations.
- Untreated negative controls:
- yes
- Remarks:
- Aqua dest.
- Negative solvent / vehicle controls:
- yes
- Remarks:
- ethanol
- Positive controls:
- yes
- Positive control substance:
- sodium azide
- methylmethanesulfonate
- other: 4-NOPD; 4-nitro-o-phenylene-diamine: TA 98, TA 1537 (without metabolic activation) 2-AA; 2-aminoanthracene: S. typhimurium: TA 98, TA 100, TA 1535, TA 1537 and E. coli WP2 uvrA (with metabolic activation)
- Details on test system and experimental conditions:
- Test System
Tester strains TA 98, TA 1535 and E. coli were obtained from MOLTOX, INC., NC 28607, USA. Tester strains TA 100 and TA 1537 were obtained from Xenometrix AG, Switzerland. All Salmonella strains contain mutations in the histidine operon, thereby imposing a requirement for histidine in the growth medium. They contain the deep rough (rfa) mutation, which deletes the polysaccharide side chain of the lipopolysaccharides of the bacterial cell surface. The other mutation is a deletion of the uvrB gene coding for a protein of the DNA nucleotide excision repair system resulting in an increased sensitivity in detecting many mutagens. This deletion also includes the nitrate reductase (chl) and biotin (bio) genes (bacteria require biotin for growth). The tester strains TA 98 and TA 100 contain the R-factor plasmid, pkM101. These strains are reverted by a number of mutagens that are detected weakly or not at all with the non R-factor parent strains. pkM101 increases chemical and spontaneous mutagenesis by enhancing an error-prone DNA repair system which is normally present in these organisms. The tester strain E. coli WP2 uvrA carries the defect in one of the genes for tryptophan biosynthesis. Tryptophan-independent mutants (revertants) can arise either by a base change at the site of the original alteration or by a base change elsewhere in the chromosome so that the original defect is suppressed.
Mammalian Microsomal Fraction S9 Mix
The bacteria most commonly used in these reverse mutation assays do not possess the enzyme system which, in mammals, is known to convert promutagens into active DNA damaging metabolites. In order to overcome this major drawback an exogenous metabolic system is added in the form of mammalian microsome enzyme activation mixture.
S9 Homogenate
The S9 liver microsomal fraction was prepared at Eurofins Munich. Male Wistar rats were induced with phenobarbital (80 mg/kg bw) and β-naphthoflavone (100 mg/kg bw) for three consecutive days by oral route.
The following quality control determinations are performed:
a) Biological activity in the Salmonella typhimurium assay using 2-aminoanthracene and benzo[a]pyrene
b) Sterility Test
A stock of the supernatant containing the microsomes was frozen in aliquots of 2 and 4 mL and stored at ≤-75 °C.
The protein concentration in the S9 preparation (Lot: 280716) was 30.3 mg/mL. In Lot 190416 the protein concentration was 34.4 mg/mL and was adjusted to 30 mg/mL.
Preparation of S9 Mix
The S9 mix preparation was performed according to Ames et al. - Evaluation criteria:
- Criteria of Validity
A test is considered acceptable if for each strain:
- the bacteria demonstrate their typical responses to ampicillin (TA 98, TA 100)
- the negative control plates (A. dest.) with and without S9 mix are within the following ranges (mean values of the spontaneous reversion frequency are within the historical control data range (2013 -2015).
- corresponding background growth on both negative control and test plates is observed.
- the positive controls show a distinct enhancement of revertant rates over the control plate.
- at least five different concentrations of each tester strain are analysable.
Evaluation of Mutagenicity
The Mutation Factor is calculated by dividing the mean value of the revertant counts by the mean values of the solvent control (the exact and not the rounded values are used for calculation).
A test item is considered as mutagenic if:
- a clear and dose-related increase in the number of revertants occurs and/or
- a biologically relevant positive response for at least one of the dose groups occurs in at least one tester strain with or without metabolic activation.
A biologically relevant increase is described as follows:
- if in tester strains TA 98, TA 100 and E. coli WP2 uvrA the number of reversions is at least twice as high
- if in tester strains TA 1535 and TA 1537 the number of reversions is at least three times higher as compared to the reversion rate of the solvent control. - Statistics:
- According to the OECD guidelines, the biological relevance of the results is the criterion for the interpretation of results, a statistical evaluation of the results is not regarded as necessary. A test item producing neither a dose related increase in the number of revertants nor a reproducible biologically relevant positive response at any of the dose groups is considered to be non-mutagenic in this system.
- Key result
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Remarks:
- ethanol
- Untreated negative controls validity:
- valid
- Remarks:
- aqua dest.
- Positive controls validity:
- valid
- Remarks:
- 4-NOPD (-S9) and 2-AA (+S9)
- Key result
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Remarks:
- ethanol
- Untreated negative controls validity:
- valid
- Remarks:
- aqua dest.
- Positive controls validity:
- valid
- Remarks:
- NaN3 (-S9) and 2-AA (+S9)
- Key result
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Remarks:
- ethanol
- Untreated negative controls validity:
- valid
- Remarks:
- aqua dest.
- Positive controls validity:
- valid
- Remarks:
- NaN3 (-S9) and 2-AA (+S9)
- Key result
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Remarks:
- ethanol
- Untreated negative controls validity:
- valid
- Remarks:
- aqua dest.
- Positive controls validity:
- valid
- Remarks:
- NaN3 (-S9) and 2-AA (+S9)
- Key result
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Remarks:
- ethanol
- Untreated negative controls validity:
- valid
- Remarks:
- aqua dest.
- Positive controls validity:
- valid
- Remarks:
- MMS (-S9) and 2-AA (+S9)
- Remarks on result:
- other: Plate-incorporation Test
- Conclusions:
- In conclusion, it can be stated that during the described mutagenicity test and under the experimental conditions reported, Isooctadecanoic acid, potassium salt did not cause gene mutations by base pair changes or frameshifts in the genome of the tester strains used. Therefore, isooctadecanoic acid, potassium salt is considered to be non-mutagenic in this bacterial reverse mutation assay.
- Executive summary:
In an OECD 471 GLP study isooctadecanoic acid, potassium salt did not cause gene mutations by base pair changes or frameshifts in the genome of the tester strains used. Therefore, Isooctadecanoic acid, potassium salt is considered to be non-mutagenic in this bacterial reverse mutation assay.
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2017
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 490 (In Vitro Mammalian Cell Gene Mutation Tests Using the Thymidine Kinase Gene)
- Deviations:
- no
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- EU Method B.17 (Mutagenicity - In Vitro Mammalian Cell Gene Mutation Test)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- in vitro mammalian cell transformation assay
- Specific details on test material used for the study:
- Product description: Potassium isooctadecanoate/potassium isostearate
Name: Isooctadecanoic acid, potassium salt
CAS No.: 66469-15-6
Physical state: off white to yellowish solid at 20 °C
Batch No.: PFS-755-169
Re-certification date of batch: 12 December 2017
Purity: 100 % (UVCB)
pH, 10% in DI water 8.0 - 9.0
Stability: stable under test conditions
Storage condition of test material: Room temperature, protected from light - Target gene:
- Thymidine kinase (TK) locus in L5178Y TK +/- mouse lymphoma cells
- Species / strain / cell type:
- mouse lymphoma L5178Y cells
- Details on mammalian cell type (if applicable):
- L5178Y TK +/- mouse lymphoma cells
- Additional strain / cell type characteristics:
- other:
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9 mix
- Test concentrations with justification for top dose:
- Based on the results of the preliminary study five concentrations of 6.25, 12.5, 25, 50 and 100 µg/mL medium for the experiments without and with metabolic activation were employed in the mutagenicity tests.
- Vehicle / solvent:
- highly purified water; The test item was completely dissolved in aqua ad iniectabilia at the evaluated concentrations.
- Untreated negative controls:
- yes
- Remarks:
- highly purified water in culture medium
- Negative solvent / vehicle controls:
- yes
- Remarks:
- highly purified water
- Positive controls:
- yes
- Positive control substance:
- 3-methylcholanthrene
- methylmethanesulfonate
- Details on test system and experimental conditions:
- Assay acceptance criteria
An assay is considered acceptable for evaluation of the test results only if all of the criteria given below are satisfied.
The activation and non-activation portions of the mutation assays are usually performed concurrently, but each portion is in fact an independent assay with its own positive and negative controls. The activation or non-activation assays would be repeated independently, as needed, to satisfy the acceptance and evaluation criteria.
- Adequate number of cells and concentrations should be analysable.
- The criteria for the selection of highest concentration are consistent with the guidline.
a) Data of the untreated/solvent control (Mutant Frequency, Cloning Efficiency and the Suspension Growth) meet the IWGT MLA Workgroup acceptance criteria (M.M. Moore et al. 2006). Relevant data is given below:
Parameter MLA (Microwell Method)
Mutant Frequency (MF) 50 - 170 x 10^-6
Cloning Efficiency (CE) 65 - 120 %
Suspension Growth (SG) 8 - 32 fold (3-4 hour treatment), 32-180 fold (24-hour treatment)
b) The positive control should demonstrate an absolute increase in total MF, that is, an increase above the spontaneous background MF [an induced MF (IMF)] of at least 300 x 10^-6. At least 40% of the IMF should be reflected in the small colony MF, or the positive control has an increase in the small colony MF of at least 150 x 10^6 above that seen in the concurrent untreated/solvent control (a small colony IMF of 150 x 10^-6).
c) Mutation Frequencies of both, negative and positive controls fall within the normal range (historical data). - Evaluation criteria:
- Assay evaluation criteria
For the MLA, significant work on biological relevance and criteria for a positive response has been conducted by The Mouse Lymphoma Expert Workgroup of the IWGT (M.M. Moore et al., 2006). Therefore, the interpretation of test chemical results is based on those recommendations:
To define positive and negative results and to assure that the increased MF is biologically relevant instead of a statistical analysis (generally used for other tests), the interpretation relies on the use of a predefined induced mutant frequency (i.e. increase in MF above concurrent control), designated as the Global Evaluation Factor (GEF). The GEF (126 x 10-6) is based on the analysis of the distribution of the negative control MF data from participating laboratories (M.M. Moore et al., 2006). Providing that all acceptability criteria are fulfilled, a test chemical is considered to be clearly positive if, in any of the experimental conditions examined, the increase in MF above the concurrent background exceeds the GEF and the increase is concentration related (e.g., using a trend test). The test chemical is then considered able to induce mutation in this test system.
Providing that all acceptability criteria are fulfilled, a test chemical is considered to be clearly negative if, in all experimental conditions examined there is no concentration related response or, if there is an increase in MF, it does not exceed the GEF. The test chemical is then considered unable to induce mutations in this test system. - Key result
- Species / strain:
- mouse lymphoma L5178Y cells
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Remarks:
- highly purified water
- Untreated negative controls validity:
- valid
- Remarks:
- highly purified water
- Positive controls validity:
- valid
- Remarks:
- 3-Methylcholanthrene (+S9), Methyl methanesulfonate (-S9)
- Additional information on results:
- No changes in pH or osmolality of the test item formulations compared to the negative control were noted up to the top concentration of 2000 µg/mL medium.
- Conclusions:
- Under the present test conditions, potassium isostearate, tested up to the cytotoxic concentration of 100 µg/mL medium, in two independent experiments was negative with respect to the mutant frequency in the L5178Y TK +/- mammalian cell mutagenicity test. In addition, no test item-related change was noted in the ratio of small to large mutant colonies. Therefore, potassium isostearate also did not exhibit any clastogenic potential at the concentration-range investigated.
- Executive summary:
In a Klimisch 1 OECD 490 GLP study, potassium isostearate, tested up to the cytotoxic concentration of 100 µg/mL medium, in two independent experiments was negative with respect to the mutant frequency in the L5178Y TK +/- mammalian cell mutagenicity test. Under these conditions, the positive controls exerted potent mutagenic effects and demonstrated the sensitivity of the test system and conditions. In addition, no test item-related change was noted in the ratio of small to large mutant colonies. Therefore, potassium isostearate also did not exhibit any clastogenic potential at the concentration-range investigated. According to the evaluation criteria for this assay, these findings indicate that potassium isostearate, tested up to the cytotoxic concentration of 100 µg/mL medium, neither induced mutations nor had any chromosomal aberration potential.
- Endpoint:
- in vitro cytogenicity / micronucleus study
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2017
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 487 (In vitro Mammalian Cell Micronucleus Test)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- in vitro mammalian cell micronucleus test
- Specific details on test material used for the study:
- Product description: Potassium isooctadecanoate/potassium isostearate
Name: Isooctadecanoic acid, potassium salt
CAS No.: 66469-15-6
Physical state: off white to yellowish solid at 20 °C
Batch No.: PFS-755-169
Re-certification date of batch: 12 December 2017
Purity: 100 % (UVCB)
pH, 10% in DI water 8.0 - 9.0
Stability: stable under test conditions
Storage condition of test material: Room temperature, protected from light - Species / strain / cell type:
- lymphocytes:
- Details on mammalian cell type (if applicable):
- Human peripheral blood was obtained by venipuncture from young, healthy, non-smoking male individuals (31 to 38 years of age) with no known recent exposures to genotoxic chemicals or radiation, and collected in heparinised vessels. Small innocula of whole blood (0.5 mL) were added to tubes containing 5 mL of Chromosome complete culture medium with Phytohemagglutinin and 1% Penicillin/Streptomycin . The tubes are sealed and incubated at 37°C, and shaken occasionally to prevent clumping.
- Additional strain / cell type characteristics:
- not specified
- Cytokinesis block (if used):
- CytoB (Cytochalasin B)
The concentration used for this assay was 5 µg/mL. - Metabolic activation:
- with and without
- Metabolic activation system:
- S9 mix
- Test concentrations with justification for top dose:
- The concentrations employed were chosen based on the results of a cytotoxicity study. In this preliminary experiment without and with metabolic activation concentrations of 3.16, 10.0, 31.6, 100, 316, 1000 and 2000 µg potassium isostearate/mL medium were employed. Complete cytotoxicity (no survival) was noted starting at a concentration of 100 µg/mL in the absence and presence of metabolic activation (24-hour or 4-hour exposure, respectively).
Hence, 100 µg/mL and one additional concentration of 200 µg/mL medium for the 4-hour exposure experiments were employed as the top concentrations for the genotoxicity tests without and with metabolic activation. - Vehicle / solvent:
- highly purified water; The test item was completely dissolved in aqua ad iniectabilia at the evaluated concentrations.
- Untreated negative controls:
- yes
- Remarks:
- highly purified water
- Negative solvent / vehicle controls:
- yes
- Remarks:
- highly purified water
- Positive controls:
- yes
- Positive control substance:
- cyclophosphamide
- mitomycin C
- other: colchicine
- Details on test system and experimental conditions:
- Culture establishment
Human peripheral blood was obtained by venipuncture from young, healthy, non-smoking male individuals (31 to 38 years of age) with no known recent exposures to genotoxic chemicals or radiation, and collected in heparinised vessels. Small innocula of whole blood (0.5 mL) were added to tubes containing 5 mL of Chromosome complete culture medium with Phytohemagglutinin and 1% Penicillin/Streptomycin . The tubes are sealed and incubated at 37°C, and shaken occasionally to prevent clumping. - Evaluation criteria:
- The assay demonstrates its ability to reliably and accurately detect substances of known aneugenic and clastogenic activity, with and without metabolic activation.
Acceptance of a test is based on the following criteria:
- The concurrent negative control is considered acceptable for addition to the laboratory historical negative control database (Poisson-based 95% control limits). Where concurrent negative control data fall outside the 95% control limits, they may be acceptable for inclusion in the historical control data as long these data are not extreme outliers.
- Concurrent positive controls induce responses that are compatible with those generated in the laboratory’s historical positive control data base and produce a statistically significant increase compared with the concurrent negative control.
- Adequate number of cells, cell proliferation criteria and concentrations are analysable.
Vehicle control and untreated cultures give reproducibly low and consistent micronucleus frequencies. Data from vehicle and positive controls are used to establish historical control ranges. These values are used in deciding the adequacy of the concurrent vehicle controls or positive controls for an experiment. - Statistics:
- Providing that all acceptability criteria are fulfilled, a test chemical is considered to be clearly positive if, in any of the experimental conditions examined:
- at least one of the test concentrations exhibits a statistically significant increase compared with the concurrent negative control
- the increase is dose-related in at least one experimental condition when evaluated with an appropriate trend test
- any of the results are outside the distribution of the historical negative control data (Poisson-based 95% control limits)
When all of these criteria are met, the test chemical is then considered able to induce chromosome breaks and/or gain or loss in this test system.
Providing that all acceptability criteria are fulfilled, a test chemical is considered clearly negative if, in all experimental conditions examined:
- none of the test concentrations exhibits a statistically significant increase compared with the concurrent negative control,
- there is no concentration-related increase when evaluated with an appropriate trend test,
- all results are inside the distribution of the historical negative control data (Poisson-based 95% control limits).
The test chemical is then considered unable to induce chromosome breaks and/or gain or loss in this test system. - Key result
- Species / strain:
- lymphocytes: Human peripheral blood
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Remarks:
- highly purified water
- Untreated negative controls validity:
- valid
- Remarks:
- highly purified water
- Positive controls validity:
- valid
- Remarks:
- Colchicine and Mitomycin C in aqua ad iniectabilia (-S9); Cyclophosphamide in aqua ad iniectabilia (+S9);
- Additional information on results:
- No changes in pH or osmolality of the test item formulations compared to the negative control were noted up to the top concentration of 2000 µg/mL medium.
- Conclusions:
- Under the present test conditions, potassium isostearate tested up to the cytotoxic concentration of 100 µg/mL medium in the absence and in the presence of metabolic activation employing two exposure times (without S9) and one exposure time (with S9) revealed no indications of chromosomal damage in the in vitro micronucleus test.
- Executive summary:
In a Klimisch 1 OECD 487 GLP study, potassium isostearate tested up to the cytotoxic concentration of 100 µg/mL medium in the absence and in the presence of metabolic activation employing two exposure times (without S9) and one exposure time (with S9) revealed no indications of chromosomal damage in the in vitro micronucleus test. The results for the vehicle controls were within historical control range. In the same test, Mitomycin C and cyclophosphamide induced significant chromosomal damage and colchicine induced significant damage to the cell division apparatus, respectively. Therefore, the test is considered valid.
Referenceopen allclose all
Results
The test item isooctadecanoic acid, potassium salt was investigated for its potential to induce gene mutations according to the plate incorporation test (experiment I and II) using Salmonella typhimurium strains TA 98, TA 100, TA 1535, TA 1537 and tester strain E. coli WP2 uvrA. In two independent experiments several concentrations of the test item were used. Each assay was conducted with and without metabolic activation. The concentrations, including the controls, were tested in triplicate. The following concentrations of the test item were prepared and used in the experiments:
Experiment I:
31.6, 100, 316, 1000, 2500 and 5000 µg/plate
Experiment II:
5.0, 15.8, 50.0, 158, 500, 1580 and 5000 µg/plate
Precipitation of the test item was observed in all tester strains used in experiment I at concentrations of 2500 µg/plate and higher (without metabolic activation) and at concentrations of 1000 µg/plate and higher (with metabolic activation). In experiment II precipitation of the test item was observed in all tester strains used at concentrations of 1580 µg/plate and higher (with and without metabolic activation). No toxic effects of the test item were noted in any of the five tester strains used up to the highest dose group evaluated with and without metabolic activation in experiment I and II. The reduction in
the number of revertants down to a mutation factor of ≤ 0.5 found in experiment I in tester strain TA 1537 at concentrations of 2500 and 5000 µg/plate (without metabolic activation) was regarded as not biologically relevant due to lack of concomitant clearing of the background lawn and the fact that this effect was not reproducible in experiment II. No biologically relevant increases in revertant colony numbers of any of the five tester strains were observed following treatment with isooctadecanoic acid, potassium salt at any concentration level, neither in the presence nor absence of metabolic activation in experiment I and II. All criteria of validity were met.
Concentration selection
A preliminary cytotoxicity study was performed to establish an appropriate concentration range for the mutation experiment. This study was performed without and with S9 metabolic activation.
A wide range of test item concentrations of 10.0, 31.6, 100, 316, 1000 and 2000 µg Potassium isostearate/mL medium were tested for cytotoxicity.
Based on the results of the preliminary study five concentrations of 6.25, 12.5, 25, 50 and 100 µg/mL medium for the experiments without and with metabolic activation were employed in the mutagenicity tests.
The separation factor of 2 was used. No increase in the mutant frequency was observed. Hence, it was considered acceptable not to add any further lower concentrations, as these additional lower concentrations would provide no further information.
Results
A preliminary study was conducted to establish the highest concentration for the main study. This study was performed without and with metabolic activation. A wide range of test item concentrations of 10.0, 31.6, 100, 316, 1000 and 2000 µg Potassium isostearate/mL medium were tested for cytotoxicity. Complete cytotoxicity (no survival) was noted starting at a concentration of 100 µg/mL in the absence and presence of metabolic activation (24-hour or 3-hour exposure, respectively). Test item precipitation was noted macroscopically at concentrations of 1000 and 2000 µg/mL medium in both experiments. Hence, 100 µg/mL were employed as the top concentration for the genotoxicity tests without and with metabolic activation. Methyl methanesulfonate (13 or 12 µg/mL) was employed as a positive control in the absence of exogenous metabolic activation and 3 Methylcholanthrene (1.0 µg/mL) in the presence of exogenous metabolic activation. In the main study, cytotoxicity (decreased relative total growth) was noted at concentrations of 50 and 100 µg Potassium isostearate/mL medium in all experiments without and with metabolic activation. In addition, cytotoxicity (decreased relative total growth) was noted at a concentration of 25 µg/mL medium in the second experiment with S9 mix. The negative controls had mutation frequencies of 158.39 or 92.54 mutant colonies per 10^6 cells in the experiments without metabolic activation (3- or 24 hour exposure, respectively) and 167.70 or 55.13 mutant colonies per 10^6 cells in the experiment with metabolic activation and, hence, were all well within the historical data-range.The mutation frequencies of the cultures treated with Potassium isostearate ranged from 60.50 to 155.53 mutant colonies per 10^6 cells (3 hour exposure), from 122.11 to 143.75 mutant colonies per 10^6 cells (24-hour exposure) in the experiments without metabolic activation. The highest concentration of 100 µg/mL medium was almost completely or complete cytotoxic (RTG=2 or 0 in the first or second assay, respectively) and, hence not used for evaluation for mutant colonies. In the experiments with metabolic activation, mutation frequencies ranged from 142.21 to 165.12 mutant colonies per 10^6 cells (3-hour exposure, first assay) and from 58.55 to 115.22 mutant colonies per 106 cells (3-hour exposure, second assay). The highest concentration of 100 µg/mL medium was almost completely or complete cytotoxic (RTG=2 or 0 in the first or second assay, respectively) and, hence not used for evaluation for mutant colonies. The results were within the range of the negative control values and the normal range of 50 to 170 mutants per 10^6 viable cells and, hence, no mutagenicity was observed according to the criteria for assay evaluation.
In addition, no increase in the ratio of small to large mutant colonies, ranging from 0.19 to 1.07 for Potassium isostearate-treated cells and ratios of 0.26 and 0.56 for the negative controls was observed.
The positive controls Methyl methanesulfonate (MMS) and 3-Methylcholanthrene (3 MC) caused pronounced increases in the mutation frequency of 774.63 and 730.89 mutant colonies per 10^6 cells in the case of MMS and of 876.76 and 930.07 mutant colonies per 10^6 cells in the case of 3-MC. As the increase in the small colony mutation frequency was at least 150 x 10^-6 above the concurrent negative control, an absolute increase in total mutation frequency was at least 300 x 10^-6 for the positive controls and the mean relative total growth (RTG) greater than or equal to 10%, the acceptance criteria for the positive controls were met.
The calculations of suspension growth of the negative controls were in the acceptance criteria range between 8 and 32 following 3-hour treatments or between 32 and 180 following 24-hour treatments. The mean cloning efficiencies (CE = PE x 100) of the negative controls from the Mutation Experiments were between the range 65% to 120%. Hence, the acceptance criteria were met.
Plating efficiency and cell growth rate - without S9 activation
1st experiment - 3 hour exposure
Culture number | Concentration of test item [µg/ml] | Wells containing cells of 192 wells | Empty wells of toal 192 wells | P | PE (viable cells) | RPE % (viable cells) | SG | RSG % | RTG |
1 | 0 (control) | 130 | 62 | 1.1304 | 0.7065 | 100 | 29.4 | 100 | 100 |
6 | 6.25 | 128 | 64 | 1.0986 | 0.6866 | 97 | 29.8 | 101 | 99 |
5 | 12.5 | 134 | 58 | 1.1971 | 0.7482 | 106 | 26.8 | 91 | 97 |
4 | 25 | 126 | 66 | 1.0678 | 0.6674 | 94 | 31.0 | 106 | 100 |
3 | 50 | 104 | 88 | 0.7802 | 0.4876 | 69 | 7.5 | 26 | 18 |
2 | 100 | 20 | 172 | 0.1100 | 0.0688 | 10 | 5.1 | 17 | 2 |
8 | MMS 13 | 85 | 107 | 0.5847 | 0.3654 | 52 | 18.5 | 63 | 33 |
Plating efficiency and cell growth rate - without S9 activation
2nd experiment - 24 hour exposure
Culture number | Concentration of test item [µg/ml] | Wells containing cells of 192 wells | Empty wells of toal 192 wells | P | PE (viable cells) | RPE % (viable cells) | SG | RSG % | RTG |
1 | 0 (control) | 133 | 59 | 1.180 | 0.7375 | 100 | 50.2 | 100 | 100 |
6 | 6.25 | 125 | 67 | 1.0528 | 0.6580 | 89 | 66 .5 | 132 | 118 |
5 |
12.5 |
130 |
62 |
1.1304 |
0.7065 |
96 |
70.5 |
140 |
134 |
4 |
25 |
127 |
65 |
1.0831 |
0.6769 |
92 |
61.8 |
123 |
113 |
3 |
50 |
66 |
126 |
0.4212 |
0.2633 |
36 |
27.4 |
54 |
19 |
2 |
100 |
0 |
192 |
0.0000 |
0.0000 |
0 |
0.0 |
0 |
0 |
8 |
MMS 12 |
63 |
129 |
0.3977 |
0.2486 |
34 |
17.4 |
35 |
12 |
Plating efficiency and cell growth rate - with S9 activation
1st experiment - 3 hour exposure
Culture number | Concentration of test item [µg/ml] | Wells containing cells of 192 wells | Empty wells of toal 192 wells | P | PE (viable cells) | RPE % (viable cells) | SG | RSG % | RTG |
9 | 0 (control) | 129 | 63 | 1.144 | 0.6965 | 100 | 26.4 | 100 | 100 |
14 | 6.25 | 125 | 67 | 1.0528 | 0.6580 | 94 | 29.8 | 113 | 107 |
13 |
12.5 |
125 |
67 |
1.0528 |
0.6580 |
94 |
27.9 |
105 |
100 |
12 |
25 |
129 |
63 |
1.1144 |
0.6965 |
100 |
30.7 |
116 |
116 |
11 |
50 |
53 |
139 |
0.3230 |
0.2019 |
29 |
18.3 |
69 |
20 |
10 |
100 |
21 |
171 |
0.1158 |
0.0724 |
10 |
6.3 |
24 |
2 |
16 |
3-MC 1.0 |
66 |
126 |
0.4212 |
0.2633 |
38 |
15.9 |
60 |
23 |
Plating efficiency and cell growth rate - with S9 activation
2nd experiment - 3 hour exposure
Cullture number | Concentration of test item [µg/ml] | Wells containing cells of 192 wells | Empty wells of toal 192 wells | P | PE (viable cells) | RPE % (viable cells) | SG | RSG % | RTG |
9 | 0 (control) | 128 | 64 | 1.0986 | 0.6866 | 100 | 19.6 | 100 | 100 |
14 | 6.25 | 140 | 52 | 1.3063 | 0.8164 | 119 | 11.6 | 59 | 71 |
13 |
12.5 |
125 |
67 |
1.0528 |
0.6580 |
96 |
18.1 |
92 |
88 |
12 |
25 |
85 |
107 |
0.5847 |
0.3654 |
53 |
18.0 |
92 |
49 |
11 |
50 |
65 |
127 |
0.4133 |
0.2583 |
38 |
5.5 |
28 |
11 |
10 |
100 |
0 |
192 |
0.0000 |
0.0000 |
0 |
6.7 |
34 |
0 |
16 |
3-MC 1.0 |
62 |
130 |
0.3900 |
0.2438 |
36 |
7.1 |
36 |
13 |
3-MC = 3-Methylcholanthrene
MMS = Methylmethansulfonate
P = probable number of clones/well
(R) PE = (relative) plating efficiency
RTG = relative total growth
RSG = relative suspension growth
SG = suspension growth
Mutant Frequency/10^6 cells without metabolic activation
1st experiment - 3 hour exposure
Culture number | Concentration of test item [µg/ml] | Wells containing mutants of total 384 wells | Pm | PEm (mutant cells) | PE (viable cells) | CE | MF/10^6 | small colony MF/10^6 |
1 | 0 (control) | 77 | 0.2238 | 1.1190E-04 | 0.7065 | 70.65 | 158.39 | 30.15 |
6 | 6.25 | 64 | 0.1823 | 9.1150E-05 | 0.6866 | 68.66 | 132.76 | 25.05 |
5 | 12.5 | 78 | 0.2271 | 1.1355E-04 | 0.7482 | 74.82 | 151.76 | 39.43 |
4 | 25 | 72 | 0.2076 | 1.0380E-04 | 0.6674 | 66.74 | 155.53 | 40.08 |
3 | 50 | 22 | 0.0590 | 2.9500E-05 | 0.4876 | 48.76 | 60.50 | 10.77 |
2 | 100 | 2 | - | - | - | - | - | - |
8 | MMS 13 | 166 | 0.5661 | 2.8305E-04 | 0.3654 | 36.54 | 774.63 | 388.89 |
Mutant Frequency/10^6 cells without metabolic activation
2nd experiment - 24 hour exposure
Culture number | Concentration of test item [µg/ml] | Wells containing mutants of total 384 wells | Pm | PEm (mutant cells) | PE (viable cells) | CE | MF/10^6 | small colony MF/10^6 |
1 | 0 (control) | 49 | 0.1365 | 6.8259E-05 | 0.7375 | 73.75 | 92.54 | 26.98 |
6 | 6.25 | 57 | 0.1607 | 8.0350E-05 | 0.6580 | 65.80 | 122.11 | 42.71 |
5 | 12.5 | 61 | 0.1730 | 8.6500E-05 | 0.7065 | 70.65 | 122.43 | 43.74 |
4 | 25 | 62 | 0.1761 | 8.8050E-05 | 0.6769 | 67.69 | 130.08 | 64.26 |
3 | 50 | 28 | 0.0757 |
3.7850E-05 |
0.2633 |
26.33 |
143.75 |
55.26 |
2 |
100 |
0 |
- |
- |
- |
- |
- |
- |
8 |
MMS 12 |
117 |
0.3634 |
1.8170E-04 |
0.2486 |
24.86 |
730.89 |
450.12 |
Mutant Frequency/10^6 cells with metabolic activation
1st experiment - 3 hour exposure
Culture number | Concentration of test item [µg/ml] | Wells containing mutants of total 384 wells | Pm | PEm (mutant cells) | PE (viable cells) | CE | MF/10^6 | small colony MF/10^6 |
9 | 0 (control) | 80 | 0.2336 | 1.1680E-04 | 0.6965 | 69.65 | 167.70 | 44.36 |
14 | 6.25 | 70 | 0.2012 | 1.0060E-04 | 0.6580 | 65.80 | 152.89 | 44.83 |
13 | 12.5 | 75 | 0.2173 | 1.0865E-04 | 0.6580 | 65.80 | 165.12 | 24.09 |
12 | 25 | 69 | 0.1981 | 9.9050E-05 | 0.6965 | 69.65 | 142.21 | 34.46 |
11 | 50 | 23 | 0.0681 |
3.0900E-05 |
0.2019 |
20.19 |
153.05 |
32.44 |
10 |
100 |
4 |
- |
- |
- |
- |
- |
- |
816 |
3-MC 1.0 |
142 |
0.4617 |
2.3085E-04 |
0.2633 |
26.33 |
876.76 |
418.72 |
Mutant Frequency/10^6 cells with metabolic activation
2nd experiment - 3 hour exposure
Culture number | Concentration of test item [µg/ml] | Wells containing mutants of total 384 wells | Pm | PEm (mutant cells) | PE (viable cells) | CE | MF/10^6 | small colony MF/10^6 |
9 | 0 (control) | 28 | 0.0757 | 3.7850E-05 | 0.6866 | 68.66 | 55.13 | 19.23 |
14 | 6.25 | 35 | 0.0956 | 4.7800E-05 | 0.8164 | 81.64 | 58.55 | 22.72 |
13 | 12.5 | 34 | 0.0927 | 4.6350E-05 | 0.6580 | 65.80 | 70.44 | 28.19 |
12 | 25 | 31 | 0.0842 | 4.2100E-05 | 0.3654 | 36.54 | 115.22 | 39.82 |
11 | 50 | 12 | 0.0317 |
1.5850E-05 |
0.2583 |
25.83 |
61.36 |
25.36 |
10 |
100 |
0 |
- |
- |
- |
- |
- |
- |
16 |
3-MC 1.0 |
140 |
0.4535 |
2.2675E-04 |
0.2438 |
24.38 |
930.07 |
506.36 |
MMS = Methylmethansulfonate
3-MC = 3 -Methylcholanthrene
Pm = probable number of clones/well
PE = plating efficiency
CE = cloning efficiency
MF/10^6 = mutant frequency per 10^6 cells
Results
In the main study cytotoxicity was noted at the top concentration of 100 µg Potassium isostearate/mL medium in the experiments without and with metabolic activation. 200 µg potassium isostearate/ml medium were completely cytotoxic.
Mitomycin C (at 0.2 µg/mL) and colchicine (at 0.02 µg/mL) were employed as positive controls in the absence and cyclophosphamide (at 20 µg/mL) in the presence of metabolic activation.
Tests without metabolic activation (4- and 24-hour exposure)
The micronucleus frequencies of cultures treated with the concentrations of 12.5, 25, 50 and 100 or 6.25, 12.5, 25, 50 and 100 µg Potassium isostearate/mL medium in the absence of metabolic activation (4- and 24-hour exposure, respectively) ranged from 4.0 to 12.0 micronucleated cells per 1000 binucleated cells. There was no dose-related increase in micronuclei up to the top concentration of 100 µg/mL medium. The frequency of micronucleated cells was within the historical control range of the untreated and vehicle controls. Vehicle controls should give reproducibly low and consistent micronucleus frequencies. In this test frequencies of 4.0 or 8.0 micronucleated cells per 1000 binucleated cells for the 4-hour and 24-hour exposure, respectively, were observed. The vehicle result was within the historical control ranges. In the positive control cultures the micronucleus frequencies were increased to 21.0 or 23.0 micronucleated cells per 1000 binucleate cells for the 4-hour and 24-hour exposure, respectively. This demonstrated that Mitomycin C induced significant chromosomal damage and colchicine induced significant damage to the cell division apparatus.
Test with metabolic activation (4-hour exposure)
The micronucleus frequencies of cultures treated with the concentrations of 12.5, 25, 50 and 100 µg Potassium isostearate/mL medium (4-h exposure) in the presence of metabolic activation ranged from 5.5 to 9.0 micronucleated cells per 1000 binucleated cells. There was no dose-related increase in micronuclei up to the top concentration of 100 µg/mL medium. The frequency of micronucleated cells was within the historical control range of the untreated and vehicle controls. Vehicle controls should give reproducibly low and consistent micronucleus frequencies. In this test a mean frequency of 7.0 micronucleated cells per 1000 binucleated cells was observed. The vehicle result was within the historical control ranges. In the positive control culture the micronucleus frequency was increased to 27.0 micronucleated cells per 1000 binucleate cells for the 4-hour exposure. This demonstrated that cyclophosphamide induced significant chromosomal damage. A summary of the results (means of the two replicate cultures) of this study is listed in Tables below. No changes in pH or in osmolality of the test item formulations compared to the negative control were noted up to the top concentration of 2000 µg/mL medium (preliminary test).
Experiment without metabolic activation (S9 mix) - 4 -h exposure
Culture number | Concentration [µl/mk medium] | mononucleate | Number of binucleate cells# | multinucleate | CBPI | RI [%] | Number of binucleate cells scored | Number of multinucleated cells per 1000 binucleate cells | Significance chi2-test |
1 | 0 (vehicle) | 265 | 236 | 8 | 1.50 | 100 | 1000 | 6 | - |
9 | 0 (vehicle) | 228 | 256 | 16 | 1.58 | 100 | 1000 | 2 | - |
6 | 12.5 | 167 | 294 | 39 | 1.74 | 148 | 1000 | 3 | n.s. |
14 | 12.5 | 157 | 307 | 36 | 1.76 | 131 | 1000 | 5 | n.s. |
5 | 25 | 206 | 260 | 34 | 1.66 | 132 | 1000 | 6 | n.s. |
13 | 25 | 192 | 284 | 24 | 1.66 | 114 | 1000 | 7 | n.s. |
4 | 50 | 278 | 211 | 11 | 1.47 | 94 | 1000 | 7 | n.s. |
12 | 50 | 217 | 270 | 13 | 1.59 | 102 | 1000 | 6 | n.s. |
3 | 100 | 379 | 101 | 20 | 1.28 | 56 | 1000 | 5 | n.s. |
11 | 100 | 403 | 83 | 14 | 1.22 | 38 | 1000 | 4 | n.s. |
2 & 10 | 200 | no binucleated cells could be evaluated due to cytotoxicity of the test item | - | - | - | - | - | - | - |
7 - Mitomycin C | 0.2 | 242 | 252 | 6 | 1.53 | 106 | 1000 | 22 | s. |
15 - Mitomycin C | 0.2 | 277 | 220 | 3 | 1.45 | 78 | 1000 | 20 | s. |
Experiment without metabolic activation (S9 mix) - 24 -h exposure
Culture number | Concentration [µl/mk medium] | mononucleate | Number of binucleate cells# | multinucleate | CBPI | RI [%] | Number of binucleate cells scored | Number of multinucleated cells per 1000 binucleate cells | Significance chi2-test |
1 | 0 (vehicle) | 278 | 207 | 15 | 1.47 | 100 | 1000 | 8 | - |
9 | 0 (vehicle) | 283 | 203 | 14 | 1.46 | 100 | 1000 | 8 | - |
6 | 6.25 | 276 | 214 | 10 | 1.47 | 100 | 1000 | 16 | n.s. |
14 | 6.25 | 293 | 200 | 7 | 1.43 | 93 |
1000 |
8 |
n.s. |
5 |
12.5 |
274 |
213 |
13 |
1.48 |
102 |
1000 |
11 |
n.s. |
13 |
12.5 |
295 |
194 |
11 |
1.43 |
93 |
1000 |
10 |
n.s. |
4 |
25 |
300 |
194 |
6 |
1.41 |
87 |
1000 |
5 |
n.s. |
12 |
25 |
287 |
203 |
10 |
1.45 |
98 |
1000 |
3 |
n.s. |
3 |
50 |
286 |
204 |
10 |
1.45 |
96 |
1000 |
3 |
n.s. |
11 |
50 |
289 |
203 |
8 |
1.44 |
96 |
1000 |
10 |
n.s. |
2 |
100 |
386 |
102 |
12 |
1.25 |
53 |
1000 |
10 |
n.s |
10 |
100 |
399 |
94 |
7 |
1.22 |
38 |
1000 |
10 |
n.s. |
7 - Colchicine |
0.02 |
333 |
156 |
11 |
1.36 |
77 |
1000 |
27 |
s. |
15- Colchicine | 0.02 | 232 | 254 | 14 | 1.56 | 122 | 1000 | 19 | s. |
Experiment with metabolic activation (S9 mix) - 4 -h exposure
Culture number | Concentration [µl/mk medium] | mononucleate | Number of binucleate cells# | multinucleate | CBPI | RI [%] | Number of binucleate cells scored | Number of multinucleated cells per 1000 binucleate cells | Significance chi2-test |
1 | 0 (vehicle) | 247 | 226 | 27 | 1.56 | 100 | 1000 | 6 | - |
9 | 0 (vehicle) | 215 | 246 | 39 | 1.65 | 100 | 1000 | 8 | - |
6 | 12.5 | 248 | 213 | 39 | 1.58 | 104 | 1000 | 8 | n.s. |
14 | 12.5 | 279 | 202 | 19 | 1.48 | 74 |
1000 |
7 |
n.s. |
5 |
25 |
223 |
255 |
22 |
1.60 |
107 |
1000 |
8 |
n.s. |
13 |
25 |
195 |
265 |
40 |
1.69 |
106 |
1000 |
10 |
n.s. |
4 |
50 |
276 |
205 |
19 |
1.49 |
88 |
1000 |
9 |
n.s. |
12 |
50 |
292 |
194 |
14 |
1.44 |
68 |
1000 |
6 |
n.s. |
3 |
100 |
348 |
144 |
8 |
1.32 |
57 |
1000 |
4 |
n.s. |
11 |
100 |
402 |
96 |
2 |
1.20 |
31 |
1000 |
7 |
n.s. |
2 |
200 |
no binucleated cells could be evaluated due to cytotoxicity of the test item |
- |
- |
- |
- |
- |
- |
n.s |
10 |
200 |
no binucleated cells could be evaluated due to cytotoxicity of the test item |
- |
- |
- |
- |
- |
- |
n.s. |
7 - Cyclophosphamide |
20 |
325 |
169 |
6 |
1.36 |
64 |
1000 |
24 |
s. |
15 - Cyclophosphamide | 20 | 322 | 173 | 5 | 1.37 | 57 |
1000 |
30 |
s. |
n.s. = not significantly different from negative control
s. = significantly different from negative control
# = at least a total of 500 cells have to be scored
CBPI = Cytokinesis block proliferation index
RI = replicative index
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Justification for classification or non-classification
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.